Ansgar Wegener - Concepedia

Concepedia

Author

Ansgar Wegener

Merck (Germany)ORCID

Also Known As

A. A. Wegener, A. Wegener, A.-A. Wegener, Ansgar A Wegener, Ansgar A. Wegener, Ansgar Wegener, Ansgar-A Wegener, Wegener, Ansgar, Wegener, Ansgar-A.

47

Publications

2.4K

Citations

23

H-Index

64

Concepts

All Affiliations

Merck (Germany)Max Planck Institute of Molecular Physiology Max Planck Society German Cancer Research Center Heidelberg University

AW

About

Ansgar Wegener is an author at Merck (Germany) specializing in biochemistry, natural sciences, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Biochemistry	15	16	1.1K
2	Medicine	12	13	1K
3	Natural Sciences	12	12	1K
4	Engineering	3	3	82
5	Health Sciences	2	2	46

Ansgar Wegener

×

30

Publications

2.4K

Citations

23

H-Index

	Year	Citations
Large-Scale Assessment of Binding Free Energy Calculations in Active Drug Discovery Projects Christina Schindler, Hannah M. Baumann, Andreas Blum, Journal of Chemical Information and Modeling	2020	292
Protein conformational flexibility modulates kinetics and thermodynamics of drug binding Marta Amaral, Daria B. Kokh, Jörg Bomke, Nature Communications	2017	283
Functional Analysis of Hsp70 Inhibitors Rainer Schlecht, Sebastian Scholz, Heike Dahmen, PLoS ONE Hsp70 InhibitorsDrug TargetMolecular BiologyChemical BiologyHsp70 Proteins	2013	194
Structural insights into the early steps of receptor-transducer signal transfer in archaeal phototaxis Ansgar Wegener The EMBO Journal BiochemistryReceptor-transducer Signal TransferNatural SciencesMechanistic PhotochemistryPhotobiology	2001	184
Time-resolved detection of transient movement of helix F in spin-labelled pharaonis sensory rhodopsin II 1 1Edited by W. Baumeister Ansgar Wegener, Igor Chizhov, Martin Engelhard, Journal of Molecular Biology Biophysical ModelingHelix FBiochemistryNatural SciencesW. Baumeister	2000	163
Discovery of Evobrutinib: An Oral, Potent, and Highly Selective, Covalent Bruton’s Tyrosine Kinase (BTK) Inhibitor for the Treatment of Immunological Diseases Richard D. Caldwell, Hui Qiu, Ben Askew, Journal of Medicinal Chemistry Novel TherapyMedicineTyrosine KinaseHighly SelectiveImmunology	2019	136
Purification of histidine tagged bacteriorhodopsin, <i>pharaonis</i> halorhodopsin and <i>pharaonis</i> sensory rhodopsin II functionally expressed in <i>Escherichia coli</i> Ilja P. Hohenfeld, Ansgar Wegener, Martin Engelhard FEBS Letters	1999	130
Ablation of the ASCT2 (SLC1A5) gene encoding a neutral amino acid transporter reveals transporter plasticity and redundancy in cancer cells Angelika Bröer, Gregory Gauthier-Coles, Farid Rahimi, Journal of Biological Chemistry Molecular BiologyOsteosarcoma CellsCancer BiologyTumor BiologyAmino Acid Homeostasis	2019	96
Structural and Biophysical Characterization of the Syk Activation Switch Ulrich Grädler, Dániel Schwarz, V. Dresing, Journal of Molecular Biology Signal TransductionSyk Activation SwitchBiophysical AspectMolecular SwitchElectrophysiology	2012	88
Sulfur as the Key Element for Quantitative Protein Analysis by Capillary Liquid Chromatography Coupled to Element Mass Spectrometry Mathias Wind, Ansgar Wegener, Andreas Eisenmenger, Angewandte Chemie International Edition Biological Mass SpectrometryMolecular BiologyGas ChromatographyBioanalysisAnalytical Chemistry	2003	87

Page 1